Two meta-analyzes of VRET for social anxiety: (1) 6 studies (n=233) confirmed VRET more effective than waitlist; (2) 7 studies (n=340) showed essentially no difference between VRET and in-vivo/imaginal exposure - supporting VRET as a non-inferior alternative to standard treatment
How this was rated
Two complementary meta-analyzes with appropriate design choices (waitlist comparison + active-comparator comparison). Peer-reviewed in Behavior Change (Cambridge University Press, established peer-reviewed cognitive-behavioral therapy journal). Lead author affiliations: University of New England (Australia). Sample sizes (n=233 + n=340) are modest but adequate for the focused research questions. Limitations: 6-7 studies per meta-analysis is small for detecting modifiers; pre-2018 cutoff misses consumer-hardware VRET (Lindner 2019, Reeves 2021, Zainal 2021); subsequent larger meta-analyzes (Horigome 2020 with 22 studies) supersede for SAD-VRET-specific synthesis.
Ratings use a simplified four-tier scheme (High, Moderate, Low, Very Low) informed by the GRADE working group. Learn more about how studies are rated.
Two complementary meta-analyzes of VRET for social anxiety published in Behavior Change. The first compared VRET to waitlist control across 6 studies (n=233), showing a significant overall effect favoring VRET - confirming VRET reduces social anxiety better than no treatment. The second compared VRET to the standard treatment (in-vivo or imaginal exposure) across 7 studies (n=340), showing essentially no difference in effect sizes between VRET and in-vivo/imaginal exposure - supporting VRET as a non-inferior alternative. Together, the two meta-analyzes establish VRET as both effective in absolute terms AND clinically equivalent to the gold-standard exposure modality.
An Australian-led 2018 meta-analysis published in Behavior Change with a clean two-part structure: (1) VRET beats waitlist (6 studies, n=233); (2) VRET is essentially equivalent to in-vivo/imaginal exposure (7 studies, n=340). This is the foundational equivalence-claim meta-analysis for VRET vs the gold standard. Subsequently incorporated as a key citation in Chard 2023's stuttering-VRET pilot trial. For clinicians making the case that VRET is a credible alternative (not a compromise) to traditional exposure, this is one of the cleanest meta-analytic citations to use.
Key findings
- Two complementary meta-analyzes published as one paper in Behavior Change
- META-ANALYSIS 1: VRET vs WAITLIST - 6 studies, n=233 participants, significant overall effect favoring VRET (specific Hedges' g reported in published article)
- META-ANALYSIS 2: VRET vs STANDARD TREATMENT (in-vivo or imaginal exposure) - 7 studies, n=340 participants, ESSENTIALLY NO DIFFERENCE in effect sizes
- Two-part design provides BOTH the absolute-effect claim (VRET works vs no treatment) AND the equivalence claim (VRET is non-inferior to in-vivo/imaginal exposure)
- Australian-led authorship (University of New England) - geographic diversification of the VRET evidence base
- Published in Behavior Change (Cambridge University Press peer-reviewed CBT journal)
- Subsequently incorporated as a key citation in Chard 2023's stuttering-VRET pilot trial (in our Hub as chard-2023) - placing it in the lineage of VRET-for-stuttering research
- Pre-2018 cutoff - misses the consumer-hardware VRET RCTs (Lindner 2019, Reeves 2021, Zainal 2021) that have transformed the modality's clinical accessibility
Background
By 2017-2018, the VRET-for-social-anxiety evidence base was substantial enough to warrant focused meta-analytic synthesis, but earlier meta-analyzes had pooled broader anxiety-disorder categories (Powers 2008, Opris 2012). What was missing was a SAD-specific meta-analysis with the dual question of (a) does VRET beat no treatment, and (b) is VRET non-inferior to the standard exposure modality?
What they did and found
Two meta-analyzes published as one paper:
- VRET vs WAITLIST: 6 studies, n=233 - significant overall effect favoring VRET.
- VRET vs STANDARD TREATMENT (in-vivo or imaginal exposure): 7 studies, n=340 - essentially NO DIFFERENCE in effect sizes.
The dual finding: VRET is more effective than no treatment AND essentially equivalent to gold-standard exposure.
Why it matters + Limitations
Foundational equivalence-claim meta-analysis. Limitations: 6-7 studies per meta-analysis is small; pre-2018 cutoff misses consumer-hardware VRET; superseded by Horigome 2020 (22 studies) for headline SAD-VRET synthesis. Use Chesham 2018 for the clean two-part absolute/equivalence framing; use Horigome 2020 for the most authoritative SAD-VRET effect estimate.
Implications for practice
For clinicians making the case that VRET is a credible alternative (not a compromise) to traditional exposure therapy, the two-part structure of this paper is unusually clean: (a) VRET reduces social anxiety more than no treatment, and (b) VRET is essentially equivalent to in-vivo/imaginal exposure. For PWS with SAD comorbidity considering VRET as an adjunct, this paper supports clinical equivalence with the gold-standard exposure modality - meaning the choice between VRET and in-vivo exposure can be made on accessibility, dose, and patient preference rather than expected efficacy. Subsequent larger meta-analyzes (Horigome 2020 with 22 studies) supersede for headline SAD-VRET synthesis, but Chesham 2018 remains the foundational equivalence-claim citation.
Cite this study
If you reference this study in your work, the canonical citation formats are:
@article{chesham2018,
author = {Chesham, R. K. and Malouff, J. M. and Schutte, N. S.},
title = {Meta-Analysis of the Efficacy of Virtual Reality Exposure Therapy for Social Anxiety},
journal = {Behaviour Change},
year = {2018},
doi = {10.1017/bec.2018.15},
url = {https://withvr.app/evidence/studies/chesham-2018}
}TY - JOUR
AU - Chesham, R. K.
AU - Malouff, J. M.
AU - Schutte, N. S.
TI - Meta-Analysis of the Efficacy of Virtual Reality Exposure Therapy for Social Anxiety
JO - Behaviour Change
PY - 2018
DO - 10.1017/bec.2018.15
UR - https://withvr.app/evidence/studies/chesham-2018
ER - Know of research that should be in this hub? If a relevant peer-reviewed study is not listed here, send the reference to hello@withvr.app. The hub is kept up to date as the literature grows.
Funding & independence
Affiliations: School of Psychology, University of New England, Armidale NSW, Australia. Specific funding sources reported in published article. Peer-reviewed in Behavior Change (Cambridge University Press). No withVR BV involvement. Summary prepared independently by withVR.